Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVYM
2851
Eaton Vance High Income Municipal ETF
EVYM
$59.7M
| $26.1M | ﹤0.01% |
511,515
-2,000
| -0.4% | -$101K |
|
2852
Star Bulk Carriers
SBLK
$3.4B
| $26M | ﹤0.01% |
1,040,248
-494,457
| -32% | -$12.8M |
|
2853
Sable Offshore Corp
SOC
$861M
| $25.9M | ﹤0.01% |
8,414,504
+1,140,502
| +16% | +$14.5M |
|
2854
Privia Health
PRVA
$2.66B
| $25.9M | ﹤0.01% |
1,005,930
+24,011
| +2% | +$556K |
|
2855
Enliven Therapeutics
ELVN
$4.24B
| $25.9M | ﹤0.01% |
509,928
-8,644
| -2% | -$367K |
|
2856
REX American Resources
REX
$1.36B
| $25.9M | ﹤0.01% |
572,684
+22,095
| +4% | +$1.02M |
|
2857
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.31B
| $25.9M | ﹤0.01% |
1,034,602
+58,506
| +6% | +$1.46M |
|
2858
Acadia Realty Trust
AKR
$2.85B
| $25.8M | ﹤0.01% |
1,236,047
-17,315
| -1% | -$370K |
|
2859
Diebold Nixdorf
DBD
$2.29B
| $25.8M | ﹤0.01% |
303,951
+151,956
| +100% | +$12.2M |
|
2860
Palomar
PLMR
$3.46B
| $25.8M | ﹤0.01% |
204,213
-5,038
| -2% | -$593K |
|
2861
T. Rowe Price Value ETF
TVAL
$1.03B
| $25.8M | ﹤0.01% |
618,978
+74,663
| +14% | +$2.97M |
|
|
CON
2862
Concentra Group Holdings
CON
$4.37B
| $25.8M | ﹤0.01% |
867,091
-106,847
| -11% | -$2.66M |
|
2863
Healthcare Services Group
HCSG
$1.54B
| $25.8M | ﹤0.01% |
1,049,627
+38,903
| +4% | +$822K |
|
2864
Establishment Labs
ESTA
$2.11B
| $25.7M | ﹤0.01% |
299,347
-106,990
| -26% | -$7.69M |
|
2865
Kyndryl
KD
$2.88B
| $25.7M | ﹤0.01% |
2,270,432
-479,925
| -17% | -$5.98M |
|
2866
Scorpio Tankers
STNG
$3.91B
| $25.7M | ﹤0.01% |
370,520
-113,259
| -23% | -$8.86M |
|
2867
Protolabs
PRLB
$1.91B
| $25.7M | ﹤0.01% |
314,778
+21,197
| +7% | +$1.49M |
|
2868
Invesco BulletShares 2027 High Yield Corporate Bond ETF
BSJR
$903M
| $25.6M | ﹤0.01% |
1,147,775
+36,185
| +3% | +$811K |
|
2869
Franklin Investment Grade Corporate ETF
FLCO
$558M
| $25.6M | ﹤0.01% |
1,194,982
+463
| +0% | +$9.91K |
|
2870
Workiva
WK
$4.31B
| $25.5M | ﹤0.01% |
526,630
+224,355
| +74% | +$11.6M |
|
|
PEPS
2871
Parametric Equity Plus ETF
PEPS
$29.7M
| $25.5M | ﹤0.01% |
795,001
| – | – |
|
2872
Lesaka Technologies
LSAK
$396M
| $25.5M | ﹤0.01% |
5,135,127
+5,515
| +0.1% | +$26.8K |
|
2873
Calumet Specialty Products
CLMT
$4.2B
| $25.5M | ﹤0.01% |
708,206
-343,791
| -33% | -$11.6M |
|
2874
Petrobras Class A
PBR.A
$108B
| $25.4M | ﹤0.01% |
1,737,536
+482,963
| +38% | +$8.51M |
|
|
EAD
2875
Allspring Income Opportunities Fund
EAD
$378M
| $25.4M | ﹤0.01% |
3,912,776
-19,563
| -0.5% | -$128K |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.